Item Details

RU-486, Status Report on the U.S. Commercialization Project, Transfer of Antiprogestin Technology to the United States [electronic resource]: Hearing Before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, Second Session, Washington, DC, May 16, 1994

United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Technology
Format
Online; EBook; Government Document
Published
Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1994.
Language
English
Series
ProQuest U.S. Congressional Hearings Digital Collection
SuDoc Number
Y 4.SM 1:103-80
Description
iii, 48 p. ; 24 cm.
System requirements: PDF reader software.
Notes
  • Record is based on bibliographic data in ProQuest Congressional Hearings Digital Collection (last viewed Nov. 2009) Reuse except for individual research requires license from ProQuest, LLC.
  • Access to the Congressional Hearings Digital Collection is restricted by license to users on UVA's network. This document may also be available in print or microform at either UVa's Alderman or Law Libraries.
  • CIS No. HRG-1994-SMB-0006
  • Record is based on bibliographic data in ProQuest Congressional Hearings Digital Collection. Reuse except for individual research requires license from ProQuest, LLC.
  • Includes bibliographical references (p. 46).
Reproduction Notes
Electronic reproduction. [Bethesda, Md.] : ProQuest, 2004. digital, PDF file. ProQuest U.S. Congressional Hearings Digital Collection. Mode of access: World Wide Web via ProQuest website.
Logo for Copyright Not EvaluatedCopyright Not Evaluated
Technical Details

  • LEADER 03201nam a22003731a 4500
    001 cis2007463779
    006 m d f
    007 cr bn mmmapmmp
    008 091024s1994 dcu sb f000 0 eng d
    043
      
      
    a| n-us---
    074
      
      
    a| 1031-A
    074
      
      
    a| 1031-B (MF)
    086
    0
      
    a| Y 4.SM 1:103-80
    088
      
      
    a| Serial no. 103-80 (United States. Congress. House. Committee on Small Business)
    110
    1
      
    a| United States. b| Congress. b| House. b| Committee on Small Business. b| Subcommittee on Regulation, Business Opportunities, and Technology.
    245
    1
    0
    a| RU-486, status report on the U.S. commercialization project, transfer of antiprogestin technology to the United States h| [electronic resource] : b| hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, second session, Washington, DC, May 16, 1994.
    260
      
      
    a| Washington : b| U.S. G.P.O. : b| For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, c| 1994.
    300
      
      
    a| iii, 48 p. ; c| 24 cm.
    500
      
      
    a| Record is based on bibliographic data in ProQuest Congressional Hearings Digital Collection (last viewed Nov. 2009) Reuse except for individual research requires license from ProQuest, LLC.
    500
      
      
    a| Access to the Congressional Hearings Digital Collection is restricted by license to users on UVA's network. This document may also be available in print or microform at either UVa's Alderman or Law Libraries.
    500
      
      
    a| CIS No. HRG-1994-SMB-0006
    500
      
      
    a| Record is based on bibliographic data in ProQuest Congressional Hearings Digital Collection. Reuse except for individual research requires license from ProQuest, LLC.
    504
      
      
    a| Includes bibliographical references (p. 46).
    533
      
      
    a| Electronic reproduction. b| [Bethesda, Md.] : c| ProQuest, d| 2004. e| digital, PDF file. n| ProQuest U.S. Congressional Hearings Digital Collection. n| Mode of access: World Wide Web via ProQuest website.
    538
      
      
    a| System requirements: PDF reader software.
    650
      
    0
    a| Mifepristone x| Government policy z| United States.
    650
      
    0
    a| Progesterone x| Antagonists x| Government policy z| United States.
    650
      
    0
    a| Pharmaceutical policy z| United States.
    776
    0
    8
    i| Print version: a| United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Technology. t| RU-486, status report on the U.S. commercialization project, transfer of antiprogestin technology to the United States w| gp 95054208 w| (OCoLC)31363910
    776
    0
    8
    i| Microfiche version: a| United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Technology. t| RU-486, status report on the U.S. commercialization project, transfer of antiprogestin technology to the United States. d| [Bethesda, Md.] : ProQuest,[2004] o| CIS 94 H721-51 w| (ProQuest)cis09401216
    830
      
    0
    a| ProQuest U.S. Congressional Hearings Digital Collection.
    856
    4
    0
    u| http://proxy.its.virginia.edu/login?url=http://congressional.proquest.com/congcomp/getdoc?HEARING-ID=HRG-1994-SMB-0006 y| Electronic resource (PDF)
    998
      
      
    a| cis09401216
    040
      
      
    a| UMI c| UMI

Availability

Read Online